A study to learn more about the safety and effects of a new blood-thinning medicine, given alone and together with another blood-thinner, in healthy adults
22806
Phase 1 other active
Quick answer
A study to learn more about the safety and effects of a new blood-thinning medicine, given alone and together with another blood-thinner, in healthy adults for atrial fibrillation, transient ischemic attack (TIA), ischemic stroke is a Phase 1 program (other) at Bayer AG with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Bayer AG
- Indication
- atrial fibrillation, transient ischemic attack (TIA), ischemic stroke
- Phase
- Phase 1
- Modality
- other
- Status
- active